- Home
- PVBC vs NYXH Comparison
PVBC vs NYXH Comparison
Compare PVBC & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PVBC
- NYXH
- Stock Information
- Founded
- PVBC 1913
- NYXH 2009
- Country
- PVBC United States
- NYXH Belgium
- Employees
- PVBC N/A
- NYXH N/A
- Industry
- PVBC Major Banks
- NYXH Medical/Dental Instruments
- Sector
- PVBC Finance
- NYXH Health Care
- Exchange
- PVBC Nasdaq
- NYXH Nasdaq
- Market Cap
- PVBC 223.5M
- NYXH 231.0M
- IPO Year
- PVBC 2015
- NYXH 2021
- Fundamental
- Price
- PVBC $12.85
- NYXH $5.86
- Analyst Decision
- PVBC Hold
- NYXH Strong Buy
- Analyst Count
- PVBC 1
- NYXH 3
- Target Price
- PVBC $12.50
- NYXH $15.00
- AVG Volume (30 Days)
- PVBC 32.8K
- NYXH 161.7K
- Earning Date
- PVBC 10-23-2025
- NYXH 11-05-2025
- Dividend Yield
- PVBC N/A
- NYXH N/A
- EPS Growth
- PVBC 47.58
- NYXH N/A
- EPS
- PVBC 0.62
- NYXH N/A
- Revenue
- PVBC $59,149,000.00
- NYXH $5,793,306.00
- Revenue This Year
- PVBC $9.73
- NYXH $144.57
- Revenue Next Year
- PVBC $4.87
- NYXH $244.36
- P/E Ratio
- PVBC $20.82
- NYXH N/A
- Revenue Growth
- PVBC 0.70
- NYXH 2.94
- 52 Week Low
- PVBC $10.09
- NYXH $5.55
- 52 Week High
- PVBC $13.02
- NYXH $11.87
- Technical
- Relative Strength Index (RSI)
- PVBC 58.28
- NYXH 35.49
- Support Level
- PVBC $12.77
- NYXH $5.60
- Resistance Level
- PVBC $12.99
- NYXH $6.13
- Average True Range (ATR)
- PVBC 0.15
- NYXH 0.30
- MACD
- PVBC 0.01
- NYXH -0.03
- Stochastic Oscillator
- PVBC 74.19
- NYXH 20.40
About PVBC Provident Bancorp Inc. (MD)
Provident Bancorp Inc provides a range of banking products and services to small and medium-sized commercial customers. It attracts deposits from the general public and uses those funds to originate loans, commercial real estate, construction and land, and commercial business loans, and to invest in securities. The company lending activities include providing commercial real estate loans, multi-family residential real estate loans, commercial business loans, construction and land development loans, one-to four-family residential loans, home equity loans & lines of credit, and consumer loans.
About NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.